Project

The role of blood protein biomarkers in the management of malignant pleural mesothelioma

Duration
01 October 2010 → 30 September 2011
Funding
Funding by bilateral agreement (private and foundations)
Research disciplines
  • Medical and health sciences
    • Diagnostics
    • Laboratory medicine
    • Palliative care and end-of-life care
    • Regenerative medicine
    • Other basic sciences
    • Diagnostics
    • Laboratory medicine
    • Palliative care and end-of-life care
    • Regenerative medicine
    • Other clinical sciences
    • Other health sciences
    • Nursing
    • Other paramedical sciences
    • Medicinal products
    • Diagnostics
    • Laboratory medicine
    • Palliative care and end-of-life care
    • Regenerative medicine
    • Other translational sciences
    • Other medical and health sciences
Keywords
mesothelioma biomarker mesothelin
 
Project description

This research work focused on malignant pleural mesothelioma, a fatal asbestos-related malignancy. The resulting doctoral thesis describes the role of three novel blood protein biomarkers, soluble mesothelin, megakaryocyte potentiating factor, and osteopontin, in different fields of mesothelioma management, including diagnosis, screening, prognosis and monitoring response to therapy.